Daratumumab plus lenalidomide and dexamethasone for untreated Myeloma

T. Facon, S. Kumar, T. Plesner, R. Z. Orlowski, P. Moreau, N. Bahlis, S. Basu, H. Nahi, C. Hulin, H. Quach, H. Goldschmidt, M. O’Dwyer, A. Perrot, C. P. Venner, K. Weisel, J. R. Mace, N. Raje, M. Attal, M. Tiab, M. MacroL. Frenzel, X. Leleu, T. Ahmadi, C. Chiu, J. Wang, R. Van Rampelbergh, C. M. Uhlar, R. Kobos, M. Qi, S. Z. Usmani

Research output: Contribution to journalArticlepeer-review

274 Scopus citations

Fingerprint

Dive into the research topics of 'Daratumumab plus lenalidomide and dexamethasone for untreated Myeloma'. Together they form a unique fingerprint.

Medicine & Life Sciences